Alirocumab for Cardiovascular Risk Reduction User Reviews (Page 2)

Brand names: Praluent

Alirocumab has an average rating of 6.4 out of 10 from a total of 27 reviews for the treatment of Cardiovascular Risk Reduction. 44% of reviewers reported a positive experience, while 26% reported a negative experience.

Reviews for Alirocumab

Pralu...
Taken for 2 to 5 years
August 7, 2023

Praluent (alirocumab) "Works great, couldn't get my cholesterol down until I went on it."

10 / 10

Was this helpful?Yes No

2 Report

Beulah...
Taken for 1 to 2 years
April 11, 2023

Praluent (alirocumab) "I am very concerned about my liver. I have sore nodules throughout, elevated liver enzymes, sore throat, red sore irritated tongue and very low serum LDL of 12."

7 / 10

Was this helpful?Yes No

1 Report

G D R...
Taken for 1 to 6 months
May 3, 2023

Praluent (alirocumab) "I had joint pain for one or two days after taking it that lasted for about 2 days. I also had muscular pain and discomfort that lasted for about a week."

7 / 10

Was this helpful?Yes No

0 Report

Frequently asked questions

Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.